| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 2008年9月，胡德明、刘清波、何林、阳辉共同出资设立亚辉龙有限。设立时，公司注册资本为1,500万元。2008年9月17日，深圳市工商行政管理局为公司颁发了《企业法人营业执照》（注册号：440301103627124）。2015年6月15日，亚辉龙有限各股东签署了《发起人协议》，同意共同作为发起人，将亚辉龙有限整体变更为股份有限公司。同日，公司创立大会暨2015年第一次临时股东大会同意亚辉龙有限整体变更为股份有限公司。根据上述协议及决议文件，各发起人将其享有的截至2015年3月31日亚辉龙有限净资产扣除个人所得税后总计人民币7,502.38万元折合为4,750.00万股，每股面值人民币1.00元，余额计入资本公积。上述整体变更已经致同会计师事务所（特殊普通合伙）于2015年6月15日出具致同验字（2015）第441ZC0267号验资报告审验。2015年7月1日，深圳市监局核准了上述变更登记。 公司系一家技术国内领先、研产销一体化的专注于临床实验室整体解决方案（包含全自动化智能流水线、智能管理软件、专业诊断仪器及配套试剂）的创新型企业，主营业务为以化学发光免疫分析法为主的体外诊断仪器及配套试剂的研发、生产和销售，及部分非自产医疗器械产品的代理销售业务。公司核心产品获得了广泛的市场认可，三甲医院占有率超过40%，形成了突出的渠道和品牌优势。公司已成长为国产化学发光领导品牌之一，在自身免疫、生殖健康、糖尿病、感染性疾病等诊断领域形成突出优势，报告期内自产产品营业收入复合增长率超过70%。公司主要产品为基于化学发光法、免疫印迹法、酶联免疫法、 免疫荧光层析法等方法学的体外诊断仪器及配套试剂。 | ||||||||||||||||||||||||
| Main Business | 以化学发光免疫分析法为主的体外诊断仪器及配套试剂的研发、生产和销售， 及部分非自产医疗器械产品的代理销售业务。 | ||||||||||||||||||||||||
| Legal Representative | 宋永波 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 王鸣阳 | ||||||||||||||||||||||||
| Solicitors | 北京市君合律师事务所 | ||||||||||||||||||||||||
| Auditors | 大华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0755-84821649 | ||||||||||||||||||||||||
| Fax No | 0755-26473319 | ||||||||||||||||||||||||
| Website | www.szyhlo.com | ||||||||||||||||||||||||
| ir@szyhlo.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 17/05/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.630 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.273 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.506 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 9.449B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |